Hoffmann-La Roche Inc. is a U.S. pharmaceuticals affiliate of F. Hoffmann-La
Roche Ltd, a global healthcare company founded in 1896 in Basel, Switzerland.
Known simply as Roche, the company is a leading innovator of medicines and
services that enhance people’s health, well-being and quality of life.
Roche businesses include pharmaceuticals and diagnostics. The company operates
in more than 60 countries, employing more than 68,000 people and selling
products in over 150 countries. In 2005, Roche worldwide sales were 35.50 billion
Swiss francs ($27.10 billion U.S.), with global pharmaceuticals sales accounting
for over 75 percent of that total.
U.S. Pharmaceuticals
The U.S. company, Roche Chemical Works, was established in lower
Manhattan, NY in 1905, later moving to our current site in Nutley,
NJ in 1928. The site currently houses about 3,000 employees on
a 127 acre campus that serves as the center of U.S. Discovery,
Development, Manufacturing, and Marketing & Sales operations
as well as the administrative ad technical functions that support
them.
To learn more about Roche affiliates in the U.S., click on www.roche.us
back
to top
Leading Roche Products
Roche markets medicines for a wide range of diseases, including: infectious
diseases, metabolic disease (including obesity and diabetes), neurology,
oncology, transplantation and virology (including hepatitis C and HIV/AIDS).
Most of our drugs are the top prescribed medicines in their therapeutic
areas, including treatments for cancer, hepatitis C, transplant,
flu and weight loss. (For more complete product information, click on the
Products section above.)
We launched the world’s first oral chemotherapy pill, Xeloda‚ (capecitabine),
for metastatic breast cancer and colorectal cancer. And globally, we are
the top pharmaceutical company (based on sales) in the oncology area. One
of the first companies involved in fighting HIV/AIDS, we’ve made tremendous
contributions, including the first protease inhibitor, Invirase®/Fortovase® (saquinavir),
and the groundbreaking fusion inhibitor, Fuzeon™ (enfuvirtide).
Pegasys® (peginterferon alfa-2a), our latest treatment for hepatitis
C, is offering hope to millions. Our influenza medicine, Tamiflu® (oseltamivir phosphate), is the world’s first
oral pill effective against all common strains of the flu virus. Oral Boniva®(ibandronate sodium) is the first and
only once-a-month medicine for the treatment of postmenopausal osteoporosis, and Boniva Injection is the first
intravenous medicine for treating postmenopausal osteoporosis and the first postmenopausal osteoporosis treatment
to be administered quarterly.We are also the U.S. leader in transplant medicine.
For complete product information, click here.
- Boniva® (ibandronate sodium): The first monthly oral and quarterly injection product for the treatment
and prevention of osteoporosis in postmenopausal women.
- CellCept® (mycophenolate mofetil):
Indicated for the prevention of rejection in patients receiving kidney, heart and liver
organ transplants.
- Fuzeon™ (enfuvirtide): Roche’s treatment for HIV/AIDS;
the first in a new class of drugs that prevent HIV from fusing with
a host
cell.
- Kytril® (granisetron HCL): Indicated
for post operative nausea and vomiting protection.
- Pegasys® (peginterferon alfa-2a): Roche’s pegylation technology
enhances the properties of interferon, making it more effective
against hepatitis C.
- Tamiflu® (oseltamivir phosphate): The #1 anti-influenza prescription
medicine in the U.S. and the world’s first oral flu pill effective
against all common strains of the flu virus.
- Valcyte® (valganciclovir hydrochloride):
Indicated for the prevention of cytomegalovirus disease in kidney, heart and kidney-pancreas transplant patients.
- Xeloda® (capecitabine): The #1 oral chemotherapeutic agent for late stage metastatic breast cancer and colorectal cancer and the world's first oral chemotherapy treatment.
- Xenical® (orlistat): The #1 prescribed weight loss drug in the U.S. and the world's first to work by blocking the intestines from absorbing approximately one-third of fat.
back
to top
|
